| Title | Drugs in Context |
| Abbreviation | Drugs Context |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Medicine (miscellaneous) (Q2); Molecular Medicine (Q2); Pharmacology (Q2) |
| h-index | 36 |
| Overall Rank/Ranking | 6099 |
| SCImago Journal Rank (SJR) | 0.811 |
| Impact Score | 2.46 |
| Publisher | BioExcel Publishing Ltd. |
| Country | United Kingdom |
| ISSN | 17404398, 17451981 |
| Best Quartile | Q2 |
| Coverage History | 2006-2008, 2012-2023 |
Drugs in Context is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q2); Molecular Medicine (Q2); Pharmacology (Q2). It is published by BioExcel Publishing Ltd.. The overall rank of Drugs in Context is 6099. According to SCImago Journal Rank (SJR), this journal is ranked 0.811. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 36. The best quartile for this journal is Q2.
The ISSN of Drugs in Context journal is 17404398, 17451981. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Drugs in Context is cited by a total of 574 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Drugs in Context is 2.46, which is computed in 2024 as per its definition. Drugs in Context IF is decreased by a factor of 0.36 and approximate percentage change is -12.77% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Drugs in Context is 2.46. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2.46 |
| 2022 | 2.82 |
| 2021 | 4.83 |
| 2020 | 5.70 |
| 2019 | 3.43 |
| 2018 | 1.04 |
| 2017 | 2.94 |
| 2016 | 3.78 |
| 2015 | 1.65 |
| 2014 | 0.94 |
Drugs in Context has an h-index of 36. It means 36 articles of this journal have more than 36 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Drugs in Context is 17404398, 17451981. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Drugs in Context is 6099. According to SCImago Journal Rank (SJR), this journal is ranked 0.811. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.811 |
| 2022 | 0.845 |
| 2021 | 1.130 |
| 2020 | 1.262 |
| 2019 | 0.848 |
| 2018 | 0.921 |
| 2017 | 1.194 |
| 2016 | 0.718 |
| 2015 | 0.681 |
| 2014 | 0.161 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 6099 |
| 2022 | 5506 |
| 2021 | 3357 |
| 2020 | 3033 |
| 2019 | 5492 |
| 2018 | 4866 |
| 2017 | 3345 |
| 2016 | 6574 |
| 2015 | 6975 |
| 2014 | 19693 |
Drugs in Context is published by BioExcel Publishing Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2006-2008, 2012-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Drugs in Context is Drugs Context. This abbreviation ('Drugs Context') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Medicine (miscellaneous) (Q2); Molecular Medicine (Q2); Pharmacology (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Drugs in Context latest impact IF is 2.46. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 5.70 (2020) and 0.94 (2014), respectively, in the last 10 years. Moreover, its average IS is 2.96 in the previous 10 years.
The Drugs in Context has an SJR (SCImago Journal Rank) of 0.811, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.262 in 2020 and the lowest being 0.161 in 2014. Furthermore, the average SJR of the Drugs in Context over the previous 10-year period stands at 2.96.
The latest h-index of the Drugs in Context is 36.
The Drugs in Context is published by the BioExcel Publishing Ltd., with its country of publication being the United Kingdom.
The Drugs in Context is currently ranked 6099 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 3033 in 2020 and its lowest position of 19693 in 2014.
The standard ISO4 abbreviation for the Drugs in Context is Drugs Context.
Drugs in Context is classified as a journal that the BioExcel Publishing Ltd. publishes.
The Drugs in Context encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Drugs in Context is assigned the following International Standard Serial Numbers (ISSN): 17404398, 17451981.
The best quartile for the Drugs in Context is Q2 (2023).
The Drugs in Context coverage history can be summarized as follows: 2006-2008, 2012-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Applied Ecology and Environmental Research | journal | 18145 | Corvinus University of Budapest | 43 | 0.77 |
| IEEE/OSA Journal of Display Technology | journal | 12809 | IEEE Computer Society | 68 | 0.00 |
| Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
| Journal of International Financial Management and Accounting | journal | 1921 | Wiley-Blackwell Publishing Ltd | 45 | 9.38 |
| International Journal of Mathematical Education in Science and Technology | journal | 8417 | Taylor and Francis Ltd. | 42 | 1.17 |
| Mathematical Modelling and Analysis | journal | 11193 | Vilnius Gediminas Technical University | 29 | 1.75 |
| Marine Biology Research | journal | 14120 | Taylor and Francis Ltd. | 45 | 1.02 |
| Palaeontographica Abteilung B: Palaeophytologie | book series | 10391 | E. Schweizerbart'sche Verlagsbuchhandlung | 17 | 3.43 |
| Archives of the Balkan Medical Union | journal | 23592 | Balkan Medical Union | 12 | 0.21 |
| Built Environment | journal | 12809 | Alexandrine Press | 46 | 1.18 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 2.46 |
| 2022 | 2.82 |
| 2021 | 4.83 |
| 2020 | 5.70 |
| 2019 | 3.43 |
| 2018 | 1.04 |
| 2017 | 2.94 |
| 2016 | 3.78 |
| 2015 | 1.65 |
| 2014 | 0.94 |
